相似文献
1
Delayed bezafibrate-induced angio-oedema in a 68-year-old man.
Br J Clin Pharmacol. 2007 Oct;64(4):560-1. doi: 10.1111/j.1365-2125.2007.02915.x. Epub 2007 Jul 4.
2
Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
Cardiovasc Diabetol. 2016 Jan 22;15:11. doi: 10.1186/s12933-016-0332-6.
3
The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia.
Eur J Clin Pharmacol. 2011 Nov;67(11):1109-17. doi: 10.1007/s00228-011-1063-y. Epub 2011 Jun 1.
4
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):100-8. doi: 10.1161/CIRCOUTCOMES.115.002104. Epub 2016 Mar 8.
5
[Bezafibrate in an infant with congenital generalized lipodystrophy and severe hypertriglyceridemia].
Arq Bras Endocrinol Metabol. 2013 Nov;57(8):653-8. doi: 10.1590/s0004-27302013000800012.
6
Lymphocyte-suppressing effects of omega-3 fatty acids in bezafibrate-treated patients with isolated hypertriglyceridemia.
Eur J Intern Med. 2012 Sep;23(6):e166-7. doi: 10.1016/j.ejim.2012.05.017. Epub 2012 Jun 18.
7
Omega-3 fatty acids enhance monocyte-suppressing effect of bezafibrate in patients with isolated hypertriglyceridemia.
Eur J Intern Med. 2012 Oct;23(7):e171-2. doi: 10.1016/j.ejim.2012.07.005. Epub 2012 Jul 31.
8
Stevens-Johnson syndrome associated with bezafibrate.
Acta Derm Venereol. 2000 Nov-Dec;80(6):457. doi: 10.1080/000155500300080457.
9
Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?
Perit Dial Int. 1999 Mar-Apr;19(2):180-2.
10
Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.
Diabetes Care. 2000 Feb;23(2):259. doi: 10.2337/diacare.23.2.259.
本文引用的文献
1
Incidence and characteristics of angioedema associated with enalapril.
Arch Intern Med. 2005 Jul 25;165(14):1637-42. doi: 10.1001/archinte.165.14.1637.
2
Severe angioedema induced by angiotensin converting enzyme inhibitors: role of precipitating factors.
J Dermatol. 2002 Jun;29(6):336-8. doi: 10.1111/j.1346-8138.2002.tb00275.x.
3
An unusual presentation of sertraline and trazodone overdose.
Ann Pharmacother. 2001 Nov;35(11):1375-7. doi: 10.1345/aph.1A021.
4
Bezafibrate-induced anaphylactic shock: unusual clinical presentation.
J Investig Allergol Clin Immunol. 2001;11(1):53-5.
5
Simultaneous mucosal and small bowel angioedema due to captopril.
South Med J. 1998 Nov;91(11):1060-3. doi: 10.1097/00007611-199811000-00015.
6
Epidemiological study of angioedema and ACE inhibitors.
Aust N Z J Med. 1996 Dec;26(6):777-82. doi: 10.1111/j.1445-5994.1996.tb00624.x.
7
Delayed onset of angioedema with angiotensin-converting enzyme inhibitors: case report and review of the literature.
Pharmacotherapy. 1996 Jul-Aug;16(4):675-9.
8
Fever, rash, and angioedema after a course of allopurinol.
Hosp Pract (1995). 1996 Mar 15;31(3):92-4.
9
Bezalip-induced anaphylaxis.
Ann Allergy Asthma Immunol. 1995 Oct;75(4):370.
Zotero 插件